Ocrelizumab in the treatment of relapsing multiple sclerosis: a Meta-analysis.

Authors
Category Systematic review
JournalChinese Journal of New Drugs
Year 2019
This article has no abstract
Epistemonikos ID: 4bf6dd8fe611ccfbf180c7f4d1ac5308d3cc363b
First added on: Sep 06, 2019